Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Poland takes steps to amend poorly disguised PMA (premarket approval) rules

This article was originally published in Clinica

Executive Summary

The Polish health ministry is now redrafting its medical device registration rules which were supposed to come into force on September 30 but which were rejected following an outcry from industry. This is a huge relief to manufacturers who had feared that the new rules were a poorly disguised attempt at a premarket approval scheme (see Clinica No 1058, p 9), which was intended to persist into the period when Poland becomes an EU member.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT063896

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel